echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > U.S. FDA lifts import ban on Huahai Pharmaceutical's southern Sichuan API production base

    U.S. FDA lifts import ban on Huahai Pharmaceutical's southern Sichuan API production base

    • Last Update: 2022-01-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 17, Huahai Pharmaceutical issued an announcement stating that the company had recently received an official letter from the US FDA that the FDA had lifted the import ban on its southern Sichuan API production base


    On October 8, 2018, Huahai Pharmaceuticals disclosed that the US FDA issued an import ban on the company’s southern Sichuan API production base inspection.


    November 9, 2021, the company has disclosed the "Zhejiang Huahai Pharmaceutical Co.


    The above-mentioned import ban issued by the FDA mainly covers the company's southern Sichuan API production base, involving 29 API products and preparation products made from APIs produced by the southern Sichuan production base


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.